| 99215 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a high level of medical decision making, and/or the… | 1,400 | $150 | $208.7K |
| 99214 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the… | 500 | $100 | $50.5K |
| Q5111 | Injection, pegfilgrastim-cbqv (udenyca), biosimilar, 0.5 mg | 310 | $110 | $33.4K |
| J0885 | Injection, epoetin alfa, (for non-esrd use), 1000 units | 3,120 | $10 | $18.7K |
| 99205 | The provider sees a new patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a high level of medical decision making, and/or the provider… | 40 | $190 | $6.7K |
| 38221 | The provider takes one or more samples of bone marrow from the sternum or pelvic bone for diagnostic purposes only. | 20 | $150 | $2.8K |
| G2212 | Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary… | 70 | $30 | $1.9K |
| 85097 | The clinician, typically a pathologist, interprets a smear prepared from a sample of bone marrow. | 30 | $60 | $1.4K |
| 38220 | The provider inserts a long, large–bore needle into the sternum or pelvic bone and aspirates (sucks out) bone marrow tissue. This procedure is used for diagnostic purposes only. | 20 | $70 | $1.3K |
| 96372 | A therapeutic, prophylactic, or diagnostic substance (a fluid, a drug, etc.) is injected via intramuscular or subcutaneous route into the patient's body. The procedure is performed by the physician… | 110 | $10 | $1.3K |